Simon Deacon, LSTH's Chief Executive Officer, has 25 years experience in expediting business growth, having founded or acquired and grown companies operating in the lighting and electronic sectors, such as UK Circuits and Light Science Technologies. Simon also co-founded a retail consultancy, Design Conformity Ltd, focused on safety and sustainability, which has been adopted by numerous global retailers and brands.

Andrew Hempsall is a highly experienced industry executive, with significant operational leadership experience. Andrew has worked in many commercial roles, driving company operations, particularly in the manufacturing sector. He has gained experience in leading teams through roles as Operations Director and General Manager – the latter of which was with PE owned, Arken POP International Limited. Andrew holds an MBA from the University of Nottingham.

Jim Snooks has held a number of Finance Director positions including as Group Financial Controller of Breasley Group, Finance Director of Furntec Ltd and Financial Controller of GLW Feeds Ltd, developing a wealth of experience in the finance operations of medium size enterprises. Jim is a CIMA chartered management accountant, CGMA global chartered management accountant and holds a BA (Hons) in European Finance and Accounting.

Myles Halley worked with KPMG LLP for over 30 years, latterly assuming a position on the UK board, where he also was a member of the audit committee. During his tenure with KPMG, Myles led the UK restructuring department of the business with over 500 employees. Subsequently, Myles became Chairman of Rcapital Partners LLP, a private equity firm, and concurrently held numerous other Chairman positions.

Rob Naylor has 24 years’ experience in capital markets. Rob was most recently at Cenkos Securities plc as head of corporate finance and corporate broking in the investment funds team. Prior to that, Robert has held roles as co-head of the investment funds team at Panmure Gordon (UK) Limited and executive director, head of product development in the investment trust team at JPMorgan Asset Management Limited. Rob has advised a number of public Healthcare and Life Science companies including BBI Holdings plc, Collagen Solutions plc, EKF Diagnostic Holdings plc, Scancell Holdings plc, Yourgene Health plc (previously Premaitha Health plc) and Immunodiagnostics Systems Holdings plc. Rob started his career with Ernst & Young LLP in 1996 where he qualified as a chartered accountant in the investment management group. Robert is the Chief Executive Officer of Intuitive Investments Group plc, the Company’s 7.6 per cent shareholder on Admission, and therefore is not considered independent.